Objective: The objective of this study was to investigate surgical outcomes and complications of hysterectomy for benign conditions other than prolapse in elderly patients and to define predictors of prolonged hospitalization. Design: Retrospective analysis of prospectively collected data. Setting: This study was conducted in an academic research center. Patients: We utilized our institution surgical database to identify patients aged 60 years or more (“elderly”) who underwent hysterectomy for benign conditions other than pelvic organ prolapse during a 20-year period (January 2000–December 2019). Methods: Length of stay (LOS) of more than 2 days (90th percentile of LOS) was defined as prolonged hospitalization. Patient demographics, comorbid conditions, and surgical approach (vaginal hysterectomy (VH), laparoscopic hysterectomy (LH), and abdominal hysterectomy (AH)) were identified. Patients treated via LH or VH were also grouped as minimally invasive surgery (MIS). Multivariable logistic regression was used to identify factors associated with prolonged LOS. Results: Overall, 334 patients were included in this study, 262 (78.4%) of whom underwent LH, 42 (12.6%) VH, and 30 (9.0%) AH. Median LOS was 2 days (1–8), and 63 (18.8%) patients required prolonged LOS. Compared to AH, median hospital stay was shorter in MIS group (2 days vs. 3 days, p < 0.001). No admission variables were associated with prolonged LOS. The only independent predictors of prolonged LOS were AH (odds ratio 24.82, 95% CI 4.84–127.16) and operative time (odds ratio for 30 mins increased 11.34, 95% CI 1.63–78.78). Compared to those who underwent VH, patients having LH had a higher rate of concomitant salpingo-oophorectomy (96.6% vs. 61.9%, p < 0.001). Limitations: Retrospective single-center study design, number of patients with prolonged hospitalization, and the setting (tertiary minimally invasive gynecology referral center), which might have reduced the generalizability of our results are the limitations of this study. Conclusions: The abdominal route of hysterectomy was found as the main driver of prolonged hospitalization, reinforcing the benefits of MIS for benign hysterectomy in elderly patients with non-prolapsed uteri; the higher chance of performing concomitant salpingo-oophorectomy supports the laparoscopic approach as the first option for these patients.

Keywords:
Hysterectomy, Elderly patients, Laparoscopic surgery, Complications, Prolonged hospitalization
1.
Wu JM, Wechter ME, Geller EJ, Nguyen TV, Visco AG. Hysterectomy rates in the United States, 2003. Obstet Gynecol. 2007;110(5):1091–5.
2.
Tyan P, Hawa N, Carey E, Urbina P, Chen FR, Sparks A, et al. Trends and perioperative outcomes across elective benign hysterectomy procedures from the ACS-NSQIP. J Minim Invasive Gynecol. 2022 Mar;29(3):365–74.e2. 2007-2017
3.
Turrentine FE, Wang H, Simpson VB, Jones RS. Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg. 2006 Dec;203(6):865–77.
4.
Toglia MR, Nolan TE. Morbidity and mortality rates of elective gynecologic surgery in the elderly woman. Am J Obstet Gynecol. 2003 Dec;189(6):1584–7; discussion 1587-9.
5.
Agrawal S, Chen L, Tergas AI, Hou JY, St Clair CM, Ananth CV, et al. Characteristics associated with prolonged length of stay after hysterectomy for benign gynecologic conditions. Am J Obstet Gynecol. 2018 Jul;219(1):89.e1–5.
6.
Walsh CA, Walsh SR, Tang TY, Slack M. Total abdominal hysterectomy versus total laparoscopic hysterectomy for benign disease: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2009 May;144(1):3–7.
7.
Caglià P, Tracia A, Buffone A, Amodeo L, Tracia L, Amodeo C, et al. Physiopathology and clinical considerations of laparoscopic surgery in the elderly. Int J Surg. 2016 Sep;33(Suppl 1):S97–102.
8.
Ciavattini A, Di Giuseppe J, Cecchi S, Tsiroglou D, Mancioli F, Stevenazzi G, et al. Gynecologic laparoscopy in patients aged 65 or more: feasibility and safety in the presence of increased comorbidity. Eur J Obstet Gynecol Reprod Biol. 2014 Apr;175:49–53.
9.
Bogani G, Cromi A, Serati M, Di Naro E, Casarin J, Pinelli C, et al. Laparoscopic and vaginal approaches to hysterectomy in the obese. Eur J Obstet Gynecol Reprod Biol. 2015 Jun;189:85–90.
10.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187–96.
11.
Casarin J, Cromi A, Bogani G, Multinu F, Uccella S, Ghezzi F. Surgical morbidity of total laparoscopic hysterectomy for benign disease: predictors of major postoperative complications. Eur J Obstet Gynecol Reprod Biol. 2021 Aug;263:210–5.
12.
Wilson RS, Hebert LE, Scherr PA, Dong X, Leurgens SE, Evans DA. Cognitive decline after hospitalization in a community population of older persons. Neurology. 2012 Mar;78(13):950–6.
13.
Wainger JJ, Yazdy GM, Handa VL. Abdominal hysterectomy and high frailty score are associated with complications among older patients. Int J Gynaecol Obstet. 2022 Sep;158(3):544–50.
14.
Jacoby VL, Autry A, Jacobson G, Domush R, Nakagawa S, Jacoby A. Nationwide use of laparoscopic hysterectomy compared with abdominal and vaginal approaches. Obstet Gynecol. 2009 Nov;114(5):1041–8.
15.
Lycke KD, Kahlert J, Damgaard R, Mogensen O, Hammer A. Trends in hysterectomy incidence rates during 2000-2015 in Denmark: shifting from abdominal to minimally invasive surgical procedures. Clin Epidemiol. 2021;13:407–16.
16.
Ghezzi F, Cromi A, Siesto G, Serati M, Bogani G, Sturla D, et al. Use of laparoscopy in older women undergoing gynecologic procedures: is it time to overcome initial concerns? Menopause. 2010;17(1):96–103.
17.
Evans EC, Matteson KA, Orejuela FJ, Alperin M, Balk EM, El-Nashar S, et al. Salpingo-oophorectomy at the time of benign hysterectomy: a systematic review. Obstet Gynecol. 2016 Sep;128(3):476–85.
18.
Erekson EA, Ratner ES, Walke LM, Fried TR. Gynecologic surgery in the geriatric patient. Obstet Gynecol. 2012 Jun;119(6):1262–9.
© 2022 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2022
You do not currently have access to this content.